Atricure Inc. buy UBS Group AG
Start price
30.04.25
/
50%
€29.29
Target price
30.04.26
€51.01
Performance (%)
4.66%
Price
24.09.25
€30.66
Summary
This prediction is currently active. With a performance of 4.66%, the BUY prediction by UBS_Group_AG for Atricure Inc. is trending in the right direction. This prediction currently runs until 30.04.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | -49.355% | -49.355% |
| iShares Core DAX® | 1.218% | -2.761% |
| iShares Nasdaq 100 | 1.942% | 4.161% |
| iShares Nikkei 225® | 1.286% | 4.232% |
| iShares S&P 500 | 1.289% | 2.565% |
Comments by UBS_Group_AG for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at UBS Group AG from $60.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat